Anticoagulation high polymer biomaterial as well as preparation method and application thereof

A biomaterial, anticoagulant technology, applied in the field of biomedical engineering, can solve the problems of heparin conformational limitation, reduced anticoagulant activity, difficult anticoagulant materials, etc., to ensure stability, durability, coating good effect

Active Publication Date: 2017-05-31
スンナテクノロジーズシャンハイカンパニーリミテッド
View PDF7 Cites 29 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the disadvantages of the heparin physical adsorption method are: heparin is easy to lose and the anticoagulant effect is not long; while the chemical reaction between the carboxyl group of heparin and the amino group of the activating material or the covalent coupling through the adhesive or spacer, through the covalent bond The disadvantages of heparin are: the conformation of heparin is limited, and the anticoagulant activity is significantly reduced; the same disadvantages are similar to using the ammonolysis method and grafting heparin after polydopamine coating on the surface of the material
The materials for immobilizing anticoagulants in existing methods are also limited, for example, many inert materials such as silica gel are difficult to immobilize anticoagulant materials through existing methods
[0004] Therefore, there is no effective anticoagulant coated medical device in the market at present.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Anticoagulation high polymer biomaterial as well as preparation method and application thereof
  • Anticoagulation high polymer biomaterial as well as preparation method and application thereof
  • Anticoagulation high polymer biomaterial as well as preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0039] Such as figure 1 and figure 2 As shown, the anticoagulant polymer biomaterial of the present invention includes the following three-layer structure: a base layer, an anticoagulant coating, and a plasma polymerized layer between the base layer and the anticoagulant coating; wherein,

[0040] The base layer is made of biomedical materials, the biomedical materials include synthetic polymer materials and natural polymer materials, wherein the synthetic polymer materials include polyurethane, silica gel and other organic silicon polymers, organic glass, nylon, polyester, polytetrafluoroethylene Vinyl fluoride, silicone rubber, polyester fiber, polyvinylpyrrolidone, polyether ether ketone, polymethyl methacrylate, polyvinyl alcohol, polylactic acid, polyethylene, etc.; natural polymer materials include chitosan, collagen, silk protein, cellulose, etc.

[0041] The plasma polymerized layer is a layer of acrylamine plasma polymerized film deposited on the base layer;

[00...

Embodiment 2

[0046] Preparation of polycarbonate surface anticoagulant polymer biomaterial based on Example 1

[0047] Put the base material (polycarbonate) into a vacuumed plasma gas generator, the air pressure is 0.05 Pa, adjust the power of the radio frequency generator to 500W, and under the condition of frequency 10 MHz, pretreat the surface of the base material to clean and oxidize the surface. The treatment time is 0.01h; then under the same conditions, use acrylamide vapor for 0.1h to deposit a layer of acrylamine plasma polymerized film on the substrate material; finally, place the plasma-treated substrate material in 10mg / ml heparin The prepared sodium cyanoborohydride buffer solution was placed on a shaker at room temperature for 12 hours, then washed with PBS, and dried to obtain an anticoagulant polymer biomaterial. The structure of anticoagulant molecules on the surface of the substrate material is as follows: figure 1 shown.

Embodiment 3

[0049] Preparation of the silica gel surface anticoagulant polymer biomaterial based on Example 1

[0050] Put the base material (silica gel) into a vacuumed plasma gas generator, the air pressure is 0.01 Pa, adjust the power of the radio frequency generator to 1000W, and the frequency is 180 MHz, pretreat the surface of the base material, clean and oxidize the surface, and the treatment time 0.02h; then under the same conditions, use acrylamide vapor treatment for 0.15h to deposit a layer of acrylamine plasma polymerized film on the substrate material; finally, put the plasma treated substrate material placed in a sodium cyanoborohydride buffer solution at room temperature for 24 hours, then washed with PBS, and dried to obtain an anticoagulant polymer biomaterial.

[0051] The coated anticoagulant polymer biomaterial was sterilized and implanted into mice, and the implantation site was taken out after 2 weeks and 4 weeks of culture, and cell immunological staining was perfor...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
concentrationaaaaaaaaaa
concentrationaaaaaaaaaa
Login to view more

Abstract

The invention discloses an anticoagulation high polymer biomaterial which comprises a substrate layer, an anticoagulation coating, and a plasma polymerization layer positioned between the substrate layer and the anticoagulation coating, wherein the substrate layer is made of a biomedical material; the plasma polymerization layer is an allylamine plasma polymerization membrane layer deposited on the substrate layer; the anticoagulation coating is an anticoagulant layer fixed on the plasma polymerization layer; and the anticoagulants comprise hirudin, heparin and the like. Anticoagulant molecules are fixedly grafted on the material surface by utilizing the pulsed plasma technology and surface heparin grafting method, and effective molecule orientation is remained by heparin molecules, so the anticoagulant performance is close to the performance of heparin molecules in the solution. Meanwhile, the heparin molecules are difficultly scoured off by blood, the persistence and stability of the anticoagulation effect are guaranteed, and the service life is long. The invention further discloses a preparation method and application of the anticoagulation high polymer biomaterial.

Description

technical field [0001] The invention relates to the field of biomedical engineering, in particular to an anticoagulant polymer composite material and its preparation method and application. Background technique [0002] Because of its excellent mechanical properties and mechanical durability, polymer materials are widely used clinically in medical devices that come into contact with human blood and tissues, such as hemodialysis systems, extracorporeal circulation systems, artificial heart valves, and cardiac pacemakers. , artificial blood vessels, vascular stents, surgical lines and catheters and their components. However, when the blood is in contact with the surface of these medical devices when used in a patient, the protein in the blood is first adsorbed on the surface of the device, then the platelets, and finally leads to the formation of a thrombus. The thrombus formed on the surface of the device, even a very small thrombus, once transported by the blood into the bl...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61L33/00C08J7/12C08J7/18
CPCA61L33/0011A61L33/0029A61L33/0041A61L33/0088C08J7/123C08J7/18C08J2369/00C08J2383/04C08J2389/00C08J2405/10C08J2433/26
Inventor 李松
Owner スンナテクノロジーズシャンハイカンパニーリミテッド
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products